Search

TIME Magazine's "Best Inventions" article highlights 200 innovative products and services selected by TIME editors for their positive impact on the world. The inventions cover a wide range of categories, from robotics and social good to household items and sustainability. Notable inventions include a robotic surgical system for microsurgery, a pouch to disconnect from cell phones, a quick at-home cold brew coffee machine, and a 3D map of the universe. These inventions aim to improve various aspects of life, from healthcare and education to sustainability and entertainment. [Extracted from the article]

This TIME Magazine article highlights the achievements and contributions of several Latino leaders in various fields. It features individuals such as Camila Mendes, Cristina Rivera Garza, Amar Santana, Tefi Pessoa, María Zardoya, Michelle Freyre, Ana Navarro, Wilson Cruz, and Isabel Casillas Guzman. These individuals have made significant contributions to their respective fields and have helped to promote diversity and representation. The article also mentions other individuals such as Hezly Rivera, Eugene Hernandez, Nava Mau, Julio Frenk, Tanya Saracho, George Lopez, Claudia Romo Edelman, and Aubrey Plaza, who have also made notable contributions and challenged stereotypes. [Extracted from the article]

This document provides brief summaries of various companies and organizations in different industries. It highlights the success and contributions of companies such as Rare Beauty, CoreWeave, Dyson, Frida, Depop, VinFast, Anthropic, Cerebras Systems, Saildrone, BYD, and Eisai. These companies are making strides in their respective fields, whether it be in beauty, technology, fashion, automotive, or pharmaceuticals. The document aims to provide library patrons with a quick overview of these companies and their recent developments. [Extracted from the article]

This article highlights the achievements of three individuals and a food-tech company. Ncuti Gatwa, a Scottish actor of Rwandan descent, has made history by becoming the first queer Black person to play the lead role in Doctor Who. Beth Koigi, a Kenyan entrepreneur, co-founded Majik Water to provide clean drinking water in arid regions. NotCo, a Chilean food-tech company, uses artificial intelligence to create plant-based food products that mimic the taste of animal-based foods. The company has experienced rapid growth and aims to focus on customer experience to make plant-based food mainstream. [Extracted from the article]

Mosquitoes are carrying serious diseases, such as eastern equine encephalitis, West Nile virus, and malaria. While the variety responsible for spreading eastern equine encephalitis has drawn attention, the most concerning type of mosquito is the Aedes mosquito, which causes most cases of malaria, dengue, yellow fever, and Zika. Mosquito populations are growing due to climate change and urbanization, making it more likely for humans to encounter infected mosquitoes. To combat this, individuals should take precautions to avoid mosquito bites, such as wearing long-sleeved clothing and using insect repellent. Researchers are also working on reducing mosquito populations through traps and genetic modification. [Extracted from the article]

Simone Biles, the most decorated gymnast in history, is not only training for her third Olympic Games but also changing the sport itself. She has five gymnastics moves named after her and continues to raise the stakes with her skills. Biles has also had a significant impact on the culture of elite gymnastics, encouraging a more lighthearted and enjoyable atmosphere. Despite facing the challenges of the sexual-abuse scandal in USA Gymnastics and her own mental health struggles, Biles remains an inspiration and role model. She continues to compete because she loves the sport and is already leaving a lasting legacy. [Extracted from the article]

The article discusses the impact of different sports on the body, focusing on injuries and long-term health effects. The data on injuries during the Olympics is limited, but it shows that sports involving direct physical contact tend to cause traumatic injuries, while endurance sports are more likely to cause chronic problems. Boxing, sport climbing, and skateboarding had the highest injury rates at the Tokyo Olympics. However, chronic injuries from repetitive motions can also have long-term effects. Gymnastics is highlighted as a sport with potential for both acute and chronic issues. Preventing injuries and using technology to protect athletes are important considerations. [Extracted from the article]

Former Green Bay Packers quarterback Brett Favre revealed his Parkinson's disease diagnosis while testifying before a congressional committee on federal welfare reform. Favre, who has previously discussed the dangers of concussions, estimated that he suffered "hundreds, maybe thousands" of concussions during his career. He also mentioned his involvement in an $8 million welfare-abuse scandal in Mississippi and investments in a company whose CEO pleaded guilty to misappropriating public funds. Favre shared his diagnosis as an explanation for losing an investment in a company developing a concussion drug. [Extracted from the article]

Using that data, Abbott has developed a monkeypox PCR test (for research purposes only) that coalition members are using to track the virus, contain its spread, and detect any changes in the viral genome as soon as they appear. A lab technician in South Africa was conducting routine genetic sequencing of random SARS-CoV-2 samples in November 2021 and noticed that the virus was missing one of three protein signatures that all the previous variants had had. That ongoing surveillance program is the predecessor to APDC; it monitors known pathogens - instead of new or emerging ones, as APDC does - for mutations that might affect diagnostic tests and treatments. The coalition serves Abbott's business purposes, given that the company has a long history of providing diagnostic tests for pathogens - including its popular BinaxNOW COVID-19 rapid at-home tests. [Extracted from the article]

The 988 Suicide and Crisis Lifeline dramatically expands the capacity of existing call centers, with the goal of instantaneously connecting people in crisis to mental-health professionals. This will be enough to mitigate most situations, but when more help is needed, dispatchers will send a mobile crisis team made up of mental-health experts and peer-support counselors, people who have recovered from their own mental-health crises and help others in similar situations. The transformative potential of 988 is huge, says Dr. Margie Balfour, chief clinical quality officer at Connections Health Solutions, a nonprofit provider of behavioral-health services in Tucson, Ariz. "This is mental-health crisis care's carpe diem moment.". [Extracted from the article]

According to a recent article in TIME Magazine, COVID-19 cases are once again surging in the United States. Data from early July showed an increase in positive COVID-19 tests and hospitalizations, particularly among the elderly. Experts attribute this uptick to waning immunity and the spread of new variants. However, while cases are climbing, deaths from COVID-19 continue to drop. Vaccines are crucial for high-risk individuals, and the CDC's expert vaccine committee has recommended an updated vaccine for the fall and winter season. Additionally, considering masking and staying home if sick are important measures to prevent the spread of the virus. [Extracted from the article]

The company's hope, says president John Burke, is that "other companies in the bike business can do the same thing." Plus, HYBE is prioritizing launching fresh talent out of Korea, Japan, and especially the U.S. "The essence of our company is IP - we are a music business company. It's currently working on research with partners like Goldman Sachs and GE Research, and in October the company, under CEO Peter Chapman, became the world's first publicly traded quantum-computing firm via a $2 billion IPO. That's very important for all companies, particularly for a company that gets credit for doing the right thing by climate. And then I think a big piece of a company scaling - not just in size, but across a lot of geographies and customer experiences - has to do with the culture inside the company. [Extracted from the article]

The article discusses outlook for the economic and social impact of the coronavirus disease 2019 (COVID-19) pandemic in 2022. Topics explored include the reported new mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, the possible contribution of the Omicron SARS-CoV-2 variant to the transition of COVID-19 to an endemic disease, and the adjustments in workplace environment which may be considered to ensure worker safety during the pandemic.

The article features several athletes that will participate in the 2022 Winter Olympics to be held in Beijing, China. Topics discussed include the passion of American speedskater Erin Jackson for inline skating, the previous records earned by Russian figure skater Kamila Valieva in women's figure skating, and the performance demonstrated by Japanese ski jumper Sara Takanashi at the 2018 Winter Olympic Games in South Korea.

The article reports on the challenges facing U.S. Centers for Disease Control and Prevention (CDC) director Rochelle Walensky amidst the surging coronavirus infections and crisis of public trust. Also cited are the emergence of the more contagious Omicron variant, how Walensky balances the economic and public health effects of the virus, and her efforts to restore the public's trust in science.

The article features gymnast Simone Biles, who withdrew from four events at the 2021 Tokyo Olympics due to mental health. Topics discussed include other athletes who have opened up about mental health which includes Michael Phelps and Naomi Osaka, rise in suicide attempts by teenage girls during the Covid-19 pandemic, according to the U.S. Centers for Disease Control and Prevention (CDC), and challenges facing Biles.

The article features scientists, Kizzmekia Corbett, Barney Graham, Katalin Kariko and Drew Weissman, who played key roles in making Covid-19 vaccines a reality. Topics discussed include process of the Covid-19 vaccines, family and educational background of Kariko, and challenges that have created vaccine inequality.

The article reports on the scheduled staging of the delayed 2020 Olympic and Paralympic Games in Tokyo, Japan from July to August 2021 amidst the COVID-19 pandemic. Also cited are the measures adopted by Games officials to prevent infections during the event like mask mandates, social-distancing procedures, and frequent testing, and the growing anti-Olympics sentiment of the Japanese people.

The article features U.S. gymnast Simone Biles. Topics discussed include sports awards received by Biles, her determination to challenge herself constantly, the struggles she experienced during the COVID-19 pandemic while preparing for the Tokyo Olympics, changes in her coaches, and the surge in her popularity and influence.

In the article, the author discusses why genetic surveillance is the appropriate solution to control future pandemics as of June 2021. Other topics include how Doctor David Ho and his team at Columbia University studied the SARS-CoV-2 virus' genetic code to find ways to eliminate it, and how the public Global Initiative on Sharing All Influenza Data (GISAID) database is helping researchers fight pandemics.

This article from TIME Magazine discusses the groundbreaking research that led to the development of weight-loss medications like Wegovy. Scientists in Europe and the U.S. made a connection between insulin and incretins, which are gut hormones known as glucagons. Researchers at the University of Copenhagen and Massachusetts General Hospital played key roles in understanding the effects of glucagon and developing GLP-1-based medications. These medications are now approved in the U.S. to treat diabetes and obesity, and there is ongoing research into their potential benefits for other diseases like Alzheimer's and Parkinson's. [Extracted from the article]

Stuart Orkin, a research scientist, has made significant progress in the treatment of sickle cell disease. His research has led to the development of the first gene therapy using CRISPR to treat the disease. By using CRISPR to turn on the fetal-hemoglobin gene, Orkin's therapy increases the production of healthy blood cells, potentially curing patients. However, the therapy is currently expensive and inaccessible to most people, so Orkin is now focused on finding a way to boost fetal hemoglobin with a pill. [Extracted from the article]

A recent article in TIME Magazine discusses the potential use of pig organs for organ transplants. Researchers at Massachusetts General Hospital successfully transplanted a genetically modified pig kidney into a human patient, marking a significant milestone in the field. The pig organs were created using gene-editing technology and contained several genetic changes to make them more compatible with the human immune system. This development could help address the shortage of organs available for transplantation and provide hope for patients on waiting lists. However, further research is needed to determine the long-term effectiveness of pig organs and their impact on patients' lives. [Extracted from the article]

Olivia Munn recently shared on Instagram that a free risk-assessment tool helped detect her higher chance of developing breast cancer. The Breast Cancer Risk Assessment Tool, available online through the National Cancer Institute, asks about a woman's age, family history of breast cancer, and other factors to estimate her risk of getting breast cancer. The tool is about 98% accurate in predicting disease risk and is especially helpful for those with a family history of breast cancer or who don't know their genetic risk. Munn's post led to a dramatic increase in visits to the tool. [Extracted from the article]

The article discusses the big role played by Illumina, a company that develops genetic sequencing machines based in California, in revealing the genetic code of COVID-19. In November 2019 that health authorities in Wuhan, China saw cases of the then mysterious pneumonia-like illness and began to genetically sequence samples to determine what they are dealing with. After revealing the genetic sequence of SARS-CoV-2, biotech firm Moderna developed a vaccine with the help of Illumina's equipment.

The article discusses the challenges of COVID-19 vaccine distribution in the U.S. Topics covered include the insufficient supply of vaccines, the difficulty of determining who is more at risk, and whether somebody has an underlying condition or not. It notes that out of some 240 million people over age 16 who need a COVID-19 vaccine, just over 42 million have been administered by early February 2021.

Hinton, 76, has spent his career trying to build AI systems that model the human brain, mostly in academia before joining Google in 2013. The neural networks that Hinton was instrumental in developing and popularizing are now the dominant AI-development paradigm, one that has allowed huge amounts of data to be ingested and processed, leading to advances in image recognition, language understanding, and self-driving cars. Time 100/AI Thinkers Over the course of February, Geoffrey Hinton, one of the most influential AI researchers of the past 50 years, had a "slow eureka moment.". [Extracted from the article]

Time 100/AI Innovators Pelonomi Moiloa didn't originally intend to work in AI. Lilly Wachowski FILMMAKER In 1999, Wachowski and her sister Lana co-created The Matrix, which warned of an AI dystopia that had an outsize effect on AI philosophers and researchers. Rootport AUTHOR OF JAPANESE MANGA Despite a lack of drawing skills, the 37-year-old Tokyo-based writer got the world's first fully AI-illustrated manga published earlier this year - with text-to-image generative AI as his digital art partner. [Extracted from the article]

Time 100/AI Innovators Ted Chiang is perhaps the world's most celebrated living science-fiction author. "But I don't want to say science fiction should have any other priorities beyond being good art." Chiang also balks at the suggestion that deflating the unlikely tales spun by technologists gives him "any kind of moral authority." Like many science-fiction authors, Chiang has written in his short stories about artificial beings with conscious inner worlds. [Extracted from the article]

Dan Hendrycks EXECUTIVE DIRECTOR, CENTER FOR AI SAFETY Alongside his work at CAIS, Hendrycks advises Elon Musk's new AI venture, xAI, on safety. Margrethe Vestager EVP, EUROPEAN COMMISSION The Danish politician has spent the past two years spearheading the E.U.'s Artificial Intelligence Act, which stands to become the world's first comprehensive AI law. Verity Harding DIRECTOR OF THE AI AND GEOPOLITICS PROJECT, CAMBRIDGE UNIVERSITY The British politico turned AI expert is leading a campaign to pursue a "rights-based" approach to AI governance that includes not just the people building AI, but also those who stand to be most impacted by it. [Extracted from the article]

Marc Andreessen ENTREPRENEUR AND INVESTOR Through his fund Andreessen Horowitz, the Silicon Valley billionaire has invested hundreds of millions into AI firms like OpenAI and Character.AI. Sam Altman CEO, OPENAI Altman's decision to gradually release OpenAI's cutting-edge AI tools, including ChatGPT, has reshaped the world of tech and rocketed AI policy up the political agenda. Time 100/AI Leaders Greg Brockman spends around 80% of his working hours coding. [Extracted from the article]

Dario, 40, and Daniela, 36 - CEO and president, respectively - believe they are taking a safer and more responsible approach to AI alignment than other companies building cutting-edge AI systems. Anthropic's leaders are notably less outspoken than other AI luminaries about the potential benefits that AI could bring to humanity's future. Time 100/AI Leaders As siblings go, Dario and Daniela Amodei agree more than most. [Extracted from the article]

The article presents an outlook for the Covid-19 pandemic after the completion of vaccination programs and a decline in cases. It suggests that Covid-19 will become increasingly manageable as more people get vaccinated. It also mentions that possibility that the virus will adopt to its host and that humans will adapt to the virus, as well as the need for elected U.S. officials, scientists and public-health officials to develop clear guidance.

The article examines the efforts by the U.S. government in controlling COVID-19, particularly the implementation of mass vaccination to achieve herd immunity, as of February 2021. Also cited are the government approval of the vaccines from Moderna and Pfizer-BioNTech, and the steps taken by President Donald Trump like appointing Army General Gus Perna to advance mass vaccination.

The article features the selection of Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), as one of the Guardians of the Year by the magazine "Time" for 2020. Fauci has been praised for his role in controlling the COVID-19 pandemic. He contradicted President Donald Trump regarding the effectiveness of hydroxychloroquine as a treatment for the virus.

The article discusses the zero coronavirus disease 2019 (COVID-19) public health policy of Chinese government officials during the 2022 Winter Olympics to be held in Beijing, China. Topics explored include the challenges associated with the hosting of the Winter Olympic Games in the midst of the COVID-19 pandemic, the travel restrictions and quarantine protocols being implemented by the Chinese government, and the need for Olympic athletes, coaches, and staff to be vaccinated against COVID-19.

The article discusses the vaccine for the corona virus behind COVID-19. It also discusses views of public-health experts on open businesses and schools, development of immunity, prediction of the virus, and records set by the National Institute of Allergy and Infectious Diseases (NIAID), and manufacturing schedules.

The article discusses the origin and other topics about the COVID-19 pandemic. Also cited are the works of Wuhan Institute of Virology (WIV) lead scientist Shi Zhengli on bat-borne diseases and viruses, how the COVID-19 virus caused a pandemic from a bat colony in Wuhan, China, and the challenges faced by scientists and governments in finding the true source of the virus, like partisan bickering and nationalism.

The article discusses the clinical trials focused on the use of antiviral drug remdesivir for the treatment of coronavirus disease 2019 (COVID-19). Topics explored include the effectiveness demonstrated by the drug against severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), the U.S. National Institute of Allergy and Infectious Diseases (NIAID) study into remdesivir published by Gilead Sciences, and the recovery of the COVID-19 patient that received remdesivir.

The article discusses how scientists and public health experts would draw up the plan to reopen the U.S. economy amid the COVID-19 pandemic. Topics covered include how the U.S. would loosen social restrictions under U.S. President Donald Trump's guidelines for Opening Up America Again, the need to boost COVID-19 testing volume and the importance of contact tracing. It also discusses the need to accept the changes to daily life brought about by the pandemic.

The article explores how public health can use technology to get ahead of future outbreaks or pandemic as serious as COVID-19. Topics discussed are efficiency of smartphone apps, data analytics and artificial intelligence (AI) in finding and treating people with an infectious disease, the app called MaNaDr used in Singapore to control escalating coronavirus cases, telemedicine as a communication tool, and usefulness of geotracking on phones in streamlining contact tracing.

The article focuses on the novel coronavirus known as COVID-19 as of March 2020. Topics include reports received by the World Health Organization (WHO), recommendations to prevent the spread of the disease from the U.S. Centers for Disease Control and Prevention (CDC), and questions surrounding the development of a vaccine.

The article features 16 people and groups who are fighting for equality in the U.S. They include Reverend William J. Barber II, a pastor at a church in Goldsboro, North Carolina who gained national attention for leading the Moral Mondays protests beginning in 2013, Dina Bakst who co-founded the legal advocacy organization A Better Balance, and Jonathan Eisen, a professor at the University of California who is an advocate for female representation at scientific conferences.

The article assesses the ability of governments to transmit scientific knowledge to contain coronaviruses (CoV). Topics discussed are importance of transparency as a strategy for responding to disease outbreaks, failure of the Chinese government to immediately address the health crisis, the need for researchers to make synthetic DNA from the viral genome, and efforts of scientists to speed up the testing of the safety and efficacy of potential drugs for 2019-nCoV through technological advances.

According to a recent report in TIME Magazine, the latest COVID-19 vaccine provides strong protection against the dominant strain of the virus. The vaccine was found to be about 54% effective in preventing symptomatic infection. Surprisingly, it was also 49% effective against the JN.1 variant, which is currently causing most new infections in the US. The vaccine's effectiveness against hospitalizations and emergency-room visits will be released in the coming weeks. It is important for high-risk individuals, such as the elderly and those with underlying health conditions, to get vaccinated as soon as possible. [Extracted from the article]

Leandris Liburd, the acting director of the Office of Health Equity at the Centers for Disease Control and Prevention, has been advocating for addressing the context in which people make choices about their health in order to address inequities in health, particularly along racial and ethnic lines. This involves promoting equal access to healthcare tools and resources, such as transportation and paid leave, to improve health outcomes for marginalized groups. Liburd emphasizes the importance of creating a more inclusive community and society, rather than focusing on differences like race. [Extracted from the article]

A recent study has found that taking a multivitamin may slow down cognitive decline in the brain associated with aging by up to two years. The study, conducted over a period of two to three years, showed consistent benefits in slowing memory loss. However, more research is needed to understand how the micronutrients in multivitamins are helping the brain and whether the benefits are due to supplementing existing diets or making up for deficits. While a multivitamin is not a substitute for a healthy lifestyle, it may help protect against memory loss when used in conjunction with other approaches. [Extracted from the article]

According to a TIME Magazine article, repeat COVID-19 infections can have harmful effects on the body, even if the symptoms are less severe than the initial infection. Studies have shown that individuals who have been infected with COVID-19 multiple times are more likely to experience long-term health issues, including heart, lung, and brain problems. Factors such as age and underlying health conditions can increase the risk of complications after repeat infections. Additionally, each infection raises the risk of developing blood clots. It is important to take precautions, such as getting vaccinated and wearing masks, to minimize the risk of multiple infections and their potential long-term effects. [Extracted from the article]

A new drug called nirsevimab has been shown to significantly reduce the risk of hospitalization for babies under 1 year old with Respiratory Syncytial Virus (RSV). The drug acts like a vaccine, training the immune system to recognize and defend against RSV. However, there have been supply issues since the drug's approval, with limited availability for pediatricians and parents. In the meantime, parents can use traditional infection-control strategies to protect their babies from RSV. [Extracted from the article]